Clinicopathological Factors Predicting Melanoma Recurrence: A Study From South East Ireland

预测黑色素瘤复发的临床病理因素:一项来自爱尔兰东南部的研究

阅读:1

Abstract

INTRODUCTION: Cutaneous malignant melanoma is a neoplastic transformation of melanocytes and a major cause of skin cancer-related mortality. Ireland, with its fair-skinned population, continues to see rising incidence rates, highlighting the importance of identifying clinicopathological predictors of recurrence. OBJECTIVES: To assess the relationship between excision margins and melanoma recurrence, with emphasis on anatomical distribution and clinicopathological features. METHODS: This retrospective observational study analyzed 565 patient records from University Hospital Waterford, Ireland, meeting predefined criteria. Data collected included age, sex, primary tumor site, disease stage, Breslow thickness, Clark level, mitotic figures, ulceration, lymphovascular invasion, sentinel lymph node involvement, and adequacy of excision margins. Statistical analysis was conducted using SPSS 26.0. RESULTS: Significant predictors of recurrence included age ≥65 years, Breslow thickness >4.0 mm, Clark level IV-V, ulceration, lymphovascular invasion (P<0.001), and positive sentinel lymph node biopsy (P=0.004). Inadequate excision margins were also linked to increased recurrence. Conversely, early-stage disease, thin Breslow lesions (≤1.0 mm), and Clark level II were associated with lower recurrence risk. CONCLUSIONS: This study demonstrates a significant association between narrow excision margins and melanoma recurrence, particularly in anatomically complex areas like the head and neck. The findings underscore the importance of individualized surgical planning to ensure oncological safety while preserving function and appearance. Adherence to excision margin guidelines and long-term follow-up are essential, especially in patients with high-risk histological features.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。